期刊文献+

丁酸钠通过信号转导和转录激活因子1抑制肝癌细胞吲哚胺2,3-双加氧酶的表达 被引量:1

Sodium butyrate inhibited the expression of indoleamine 2, 3-dioxygenase by inhibiting phosphoryl. ation of signal transducers and activators of transcription 1 in HepG2 Cells
原文传递
导出
摘要 目的观察丁酸钠(NaB)对干扰素-1(IFN-1)诱导的人肝癌细胞HepG2内吲哚胺2,3-双加氧酶(IDO)表达的影响。方法利用低浓度(10、20、30、40mmol/L)的NaB作用于人肝癌细胞HepG224h,通过噻唑蓝(MTT)比色法检测细胞的增殖;利用蛋白印迹法及细胞免疫化学法检测NaB对HepG2细胞内IDO表达的影响;蛋白印迹法检测NaB对IDO基因表达的关键性干扰素应答因子1(IRF.1)及信号转导和转录激活因子1(STAT1)的影响。结果低浓度NaB对人肝癌细胞HepG2的增殖具有1%-20%的抑制作用;3mmol/L的NaB能完全抑制IFN-1诱导的IDO的表达;这种抑制作用通过抑制STAT-1701位的酪氨酸磷酸化实现。结论NaB通过抑制STAT1的磷酸化而抑制肝癌细胞HepG2中IDO的表达。 Objective To investigate the effect of sodium butyrate (NAB) on the expression of in- doleamine 2, 3-dioxygenase (IDO) induced by interferon (IFN)-γ in HepG2 cells. Methods HepG2 cells were treated with low concentration of NaB for 24 h, such as 10, 20, 30 and 40 mmol/L, and the proliferation of the cells was detected by methyl thiazolyl tetrazolium (MTlP) assay. The effects of NaB on IDO expression induced by IFN-~/ in HepG2 cells were demonstrated by Western blotting and immunocyto- chemistry. The transcription of interferon responsive factor-1 ( IRF-1 ) and signal transducers and activators of transcription 1 ( STAT1 ), which were key transcription factor regulating IDO expression, were analyzed by Western blotting. Results Low concentration of NaB inhibited the proliferation of HepG2 cells, varying from 1% to 20%. And the expression of IDO in HepG2 cells was completely inhibited by 3 mmol/L NaB through inhibition of the phosphorylation of STAT1 ( tyrosine at 701 site). Conclusion NaB could inhibit the expression of IDO in HepG2 cells through inhibiting STAT1 phosphorylation.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2012年第3期435-437,共3页 Chinese Journal of Experimental Surgery
关键词 丁酸钠 肝癌 吲哚胺2 3-双加氧酶 Sodium butyrate Hepatocellular carcinoma Indoleamine 2,3-dioxygenase
  • 相关文献

参考文献10

  • 1Munn DH, Mellor AL. Indoleamine 2,3-dioxygenase and tumor induced tolerance. J Clin Invest,2007,117 : 1147-1154.
  • 2Nakamura T, Shima T, Saeki A, et al. Expression of indoleamine 2,3- dioxygenase and the recruitment of Foxp3-expressing regulatory T cells in the development and progression of uterine cervical cancer. Cancer Sci ,2007,98:874-881.
  • 3Chen W, Liang X, Peterson AJ, et al. The indoleamine 2,3-dioxygen- ase pathway is essential for human plasmacytoid dendritic cell-in- duced adaptive T regulatory cell generation. J Immunol,2008,181: 5396-5404.
  • 4Dereanne CF, Bonjean K, Servotte S, et al. Histone deacetylases inhib- itors as anti-angiogenie agents altering vascular endothelial growth fac- tor signaling. Oncogene ,2002,21:427-436.
  • 5Tim FG, Michaal PM, Firouzeh K. Immunotherapy of hepatocellular caicinoma. J Hepatol,2006,45:868-878.
  • 6Pan K,Wang H,Chen MS,et al. Expression and prognosis role of in- doleamine 2,3-dioxygenase in hepatocellular carcinoma. J Cancer Res Clin Oncol, 2008,134 : 1247 -1253.
  • 7Sakatsume M, Igarashi K, Winestock KD, et al. The JAK kinases dif- ferentially associate with the alpha and beta ( accessory factor) chains of the interferon gamma receptor to form a functional receptor unit ca- pable of activating STAT transcription factors. J Biol Chem, 1995, 270 : 17528-17534.
  • 8Jiang GM, He YW, Fang R, et al. Sodium butyrate downregulation of indoleamine 2,3-dioxygenase at the transcriptional and post-transcrip- tional levels. Int J Biochem Cell B .2010.42:1840-1846.
  • 9王波涌,邵荣江,雷道雄,艾中立.丁酸钠诱导人肝癌细胞凋亡机制[J].中华实验外科杂志,2006,23(11):1412-1412. 被引量:4
  • 10奚玲,陈刚,吴鹏,王蓓蓓,周剑锋,马丁.丁酸钠诱导MCF-7细胞凋亡反义cDNA文库的构建和初步鉴定[J].中华实验外科杂志,2006,23(7):807-809. 被引量:1

二级参考文献11

  • 1奚玲,吴明富,吴剑宏,李辅军,卢运萍,周剑锋,马丁.丁酸钠诱导MCF-7细胞凋亡过程中端粒酶活性的变化[J].中华肿瘤杂志,2005,27(1):9-12. 被引量:6
  • 2Louis P, Deiss DA, Adi K. A genetic tool used to identify thioredoxin as a mediator of a growth inhibition signal. Science, 1991,252:117-120.
  • 3Angell JE, Lindner DJ, Shapiro PS, et al. Identification of GRIM-19, a novel cell death-regulatory gene induced by the interferon-beta and retinoic acid combination, using a genetic approach. J Biol Chem, 2000,275 : 33416-33426.
  • 4Marks P, Rifkind RA, Richon VM, et al. Histone deacetylases and cancer: causes and therapies. Nature reviews( Cancer ), 2001, 1 : 195-202.
  • 5Kim DH, Kim M, Kwon HJ. Histone deacetylase in carcinogenesis and its inhibitors as anti-cancer agents. J Biochem Mol Biol, 2003, 36:110-119.
  • 6Wakabayashi K, Saito H, Kaneko F, et al.Gene expression associated with the decrease in malignant phenotype of human liver cancer ceils following stimulation with a histone deacetylase inhibitor. Int J Oncol, 2005,26 :233-239.
  • 7Gartel AL, Radhakrishnan SK. Lost in transcription: p21 repression, mechanisms, and consequences. Cancer Res, 2005, 65: 3980-3985.
  • 8李丰,吴一迪,王芸庆,宋今丹.分离丁酸钠诱导人大肠癌新分化相关基因的mRNA差异显示技术的一些改进[J].中国医科大学学报,2000,29(5):325-328. 被引量:1
  • 9晏伟,李青,朱峰,岳文,柴玉波,王成济,路凡,赵忠良.改良消减杂交法克隆人乳腺癌MCF-7细胞凋亡相关基因[J].中华肿瘤杂志,2001,23(3):193-195. 被引量:9
  • 10张强,陈琳,梁丽莉,郭晓健,张志文,丁义,佟明,郭应禄.肾癌组织消减文库的构建与肾癌特异表达基因克隆[J].中华实验外科杂志,2001,18(4):338-339. 被引量:2

共引文献3

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部